Clinical Trial Update: Prevent/Delay Development of Type 2 Diabetes in Subjects With Impaired Glucose Homeostasis Treated With Acarbose in Primary Care [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated acarbose for preventing or delaying progression to type 2 diabetes in people with impaired glucose homeostasis; the study status is co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes
• Type 2 Diabetes Mellitus

Drugs mentioned

• acarbose (Precose) (acarbose)

Snippet

Sponsor: Bayer | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED